StockData
NovaBridge Biosciences logo

NovaBridge Biosciences (NBP) stock

NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 0/30
$0.82+0.03 (+3.89%)

Close on Nov 17, 2026Market cap $94.88MP/E –Yield –

NovaBridge Biosciences operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

NovaBridge Biosciences's operating cash flow for the twelve months ending Dec 31, 2020 was CN¥433.56M. For fiscal 2023 it was -CN¥1.30B. The highest annual figure on record is CN¥433.56M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2023Dec 31, 2023-CN¥1.30B–
FY2022Dec 31, 2022-CN¥1.10B–
FY2021Dec 31, 2021-CN¥973.09M-324.4%
FY2020Dec 31, 2020CN¥433.56M–
FY2019Dec 31, 2019-CN¥867.98M–
FY2018Dec 31, 2018-CN¥280.71M–
FY2017Dec 31, 2017-CN¥252.16M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2020Dec 31, 2020CN¥1.02B–
Q4 FY2019Dec 31, 2019-CN¥215.99M–

More NovaBridge Biosciences figures

See a number that looks wrong?